# Clinical Study of Irinotecan Liposome (II)-Based Combination Treatment for Irinotecan-resistant Colorectal Cancer.

Source: https://onco.cc/trials/nct07044921/  
OnCo record `nct07044921` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of cetuximab in colorectal cancer, run by Chinese PLA General Hospital, now recruiting.

## Summary

Clinical Study of Irinotecan Liposome (II)-Based Combination Treatment for Irinotecan-resistant Colorectal Cancer. is a phase 2, interventional study registered as NCT07044921 by Chinese PLA General Hospital, with a registry enrolment figure of 30 participants, started 2024-09-01 and due to reach its primary completion in 2026-07-31. Interventions recorded: Irinotecan Liposomes (II)+Cetuximab+Bevacizumabl. Conditions listed: Colorectal Cancer Metastatic. Primary outcome: PFS. Colorectal eligibility wording from the registry: "* patients with pathologically confirmed advanced colorectal cancer(excluding all other histological types);". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Tags: ctgov-ingest; colorectal-deep-dive
- Registry id: NCT07044921
- Phase: 2
- Setting: A Single-center Phase II Clinical Study of Irinotecan Liposome (II)-Based Combination Regimen as a Treatment for Irinotecan-Resistant Colorectal Cancer.
- Sponsor: Chinese PLA General Hospital
- Enrolled: 30

## Sources

- ClinicalTrials.gov NCT07044921: https://clinicaltrials.gov/study/NCT07044921

## Connected records

- cancers: [Colon cancer (adenocarcinoma of the colon)](https://onco.cc/cancers/colon-cancer/), [Rectal cancer](https://onco.cc/cancers/rectal-cancer/)
- technologies: [Monoclonal antibodies](https://onco.cc/technologies/monoclonal-antibody/)
- drugs: [Cetuximab](https://onco.cc/drugs/cetuximab/)
- terms: [Colorectal cancer trials open today (registry snapshot)](https://onco.cc/terms/colorectal-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct07044921.json